by Jon Fleetwood,Jon Fleetwood:
Nearly every vaccine recipient becomes producer and emitter of the very virus the vaccine is said to target.
A newly published, U.S. government-funded, peer-reviewed study has confirmed that a live attenuated influenza vaccine caused detectable post-vaccination viral shedding in more than 91% of adult recipients, raising major questions about whether vaccinated individuals function as carriers and spreaders of vaccine-derived influenza pathogens after immunization.
TRUTH LIVES on athttps://sgtreport.tv/
The findings, published Thursday in the journalClinical Infectious Diseases, claim that the purported virus inside the vaccine actively replicated inside recipients after administration and was subsequently shed from the nose in the overwhelming majority of participants.
Researchers from George Washington University evaluated 283 healthy adults between the ages of 18 and 49 who received the intranasal live attenuated influenza vaccine (LAIV),FluMist, during the 2023–2024 and 2024–2025 flu seasons.
According to theFDA insert, FluMist is said to contain live influenza viruses designed to reproduce inside the upper respiratory tract after administration.
The new paper explicitly states:
“LAIV replication begins within 24 hours and declines over the first week…”
Researchers further explained that the virus in the vaccine:
Source: SGT Report
